Bid to calm fears over 'untested' swine flu vaccine
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A senior adviser to the Government moved to calm concerns over the swine flu vaccine today after questions were raised about whether it will have been sufficiently tested before it is used.
Professor Sir Gordon Duff, co-chairman of the Scientific Advisory Group for Emergencies, said the benefits far outweighed any potential risks.
The first deliveries of the vaccine are expected in August. But a spokesman for the European Medicines Agency told The Independent: "What the manufacturers will be submitting will not have any clinical trial data. We expect the interim adult data from September and the first paediatric data from October onwards."
The Department of Health said the vaccine would be safe and warned that any suggestion otherwise would create unnecessary panic.
Sir Gordon, who is also chairman of the Scientific Pandemic Influenza Advisory Committee, told the Press Association: "We are content that benefits far outweigh the risks."
He said the companies preparing the vaccine had been working on "core" vaccines which had been tested on 6,000 people.
"In a pandemic, you can't predict what the virus is going to be, so to make a vaccine you use a similar virus. These core vaccines have been tested on 5,000-6,000 people already, with no serious adverse effects.
"It is inconceivable that in the UK we would consider a vaccine without giving a full scientific appraisal of its benefits and theoretical risks. That is just what these risks are - theoretical."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments